期刊文献+

放疗联合热疗治疗原发性巨块型肝癌临床疗效观察 被引量:3

Clinical observation of radiotherapy combined with hyperthermia in the treatment of primary giant liver cancer
暂未订购
导出
摘要 目的:比较应用单纯三维适形放疗与三维适形放疗联合局部热疗治疗无法手术切除的巨块型肝癌的临床疗效。方法:64例无法手术切除的巨块型肝癌患者,对照组单纯应用三维适形放疗,每周5次,每次2Gy,总剂量50-60Gy。治疗组应用三维适形放疗联合局部体外热疗,热疗在放疗后30分钟进行,每周2次,每次1小时。结果:治疗后3月内复查,对照组治疗后完全缓解(CR)1例,部分缓解(PR)20例,稳定(SD)6例,疾病进展(PD)3例,总有效率为70%。治疗组治疗后完全缓解(CR)3例,部分缓解(PR)23例,稳定(SD)6例,疾病进展(PD)2例,总有效率为76.4%。P<0.05。放疗及热疗引起的不良反应可以耐受,而肝功能无明显损害加重。随访1年的生存期为65.5%,与对照组62.8%相比,P值>0.05无统计学意义。结论:三维适形放疗联合热疗治疗不能手术的巨块型肝癌近期疗效确切,不良反应可耐受,是一种可以在临床应用的方法。 Objective: To compare the clinical effect of three-dimensional conformal radiation therapy alone and three-dimensional conformal radiotherapy combined with local hyperthermia in treatment of unresectable giant liver cancer.Methods: All 64 cases of unresectable giant hepatocellular carcinoma patients,the control group with simple application of three-dimensional conformal radiotherapy,5 times a week,each time 2Gy,total dose 50-60Gy.Treatment group,three-dimensional conformal radiotherapy combined with local hyperthermia in vitro,hyperthermia at 30 minutes after radiotherapy,2 times a week,each time 1 hour.Results: To review after 3 months,in control group,complete remission after treatment(CR) 1 case and partial remission(PR) 20 cases,stable(SD) 6 cases and progressive disease(PD) 3 cases,the total effective rate was 70%.After treatment,in treatment group complete remission(CR) 3 cases and partial remission(PR) 23 cases,stable(SD) 6 cases and progressive disease(PD) 2 cases,the total effective rate was 76.4%.P 0.05.Side effects caused by radiotherapy and hyperthermia can be tolerated,and no significant damage for liver function.1-year survival of the treatment group was 65.5% compared with 62.8% of the control group,P 0.05.Conclusion: Three-dimensional conformal radiotherapy combined with hyperthermia in the treatment of inoperable giant liver cancer has clear short-term curative effect and adverse reactions could be tolerated.So it is a feasible method in clinical application.
出处 《现代肿瘤医学》 CAS 2012年第4期774-776,共3页 Journal of Modern Oncology
关键词 肝癌 放疗 热疗 hepatocellular carcinoma radiotherapy hyperthermia
  • 相关文献

参考文献13

二级参考文献46

共引文献133

同被引文献26

  • 1Shi, Ming,Chen, Ji-An,Lin, Xiao-Jun,Guo, Rong-Ping,Yuan, Yun-Fei,Chen, Min-Shan,Zhang, Ya-Qi,Li, Jin-Qing.Transarterial chemoembolization as initial treatment for unresectable hepatocellular carcinoma in southern China[J].World Journal of Gastroenterology,2010,16(2):264-269. 被引量:37
  • 2汤钊酞,主编.现代肿瘤学[M].第2版.上海:上海医科大学出版社,2000:750.
  • 3Lin ZY,Chuang WL.Hepatocellular carcinoma cells cause different responses in expressions of cancer-promoting genes in different cancer-associated fibroblasts[J].Kaohsiung J Med Sci,2013,29(6):312.
  • 4Yu MW, Yeh SH, Chen P J, et al. Hepatitis B virus genotype ang DNA level ang hepatocellular carcinoma: a prospective study in men[J]. J Natl Cancer Inst,2005,97:265-272.
  • 5Park NH, Chung YH. Molecular mechanisms of hepatitis B virus associated hepatocellular carcinoma[J]. Korean J Hepatol,2007,13:320- 324.
  • 6Yu MW, Yeh SH, Chen P J, et al. Hepatitis B virus genotype and DNA level and hepatocellular carcinoma:a prospective study in men[J]. J Natl Cancer Inst.2005.97:265-272.
  • 7Park HC, Seong J, Han KI-I, et al. Dose response relationship in local radiotherapy for hepatocellular carcinoma [J]. Int J Radiat Oncol Biol Phys,2002,54:150-155.
  • 8Abou-Alfa GK, Schwartz L, Ricci s, et al. Phase Ⅱ study of sorafbnib in patients witll advanced hepatocellucarcinoma [J]. J Clin Oncol, 2006,24:4293 -4300.
  • 9梁松年,刘琳琳,苏洪英,冯博,赵广生,徐克.原发性肝癌行肝动脉化疗栓塞术后的并发症及其分析[J].中华肿瘤杂志,2008,30(10):790-792. 被引量:10
  • 10戴文英,於霞,莫文梅,陈民为,汤利英.“五指疼痛评分模型”在疼痛评估中的应用[J].中国实用护理杂志(中旬版),2009,25(3):11-13. 被引量:34

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部